Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Critical IllnessInfection
Interventions
DRUG

Caspofungin

In accordance with routine clinical practice, Caspofungin will be given at the loading dose of 70 mg followed by 50 mg daily (for people \< 80 kg body weight). No dose reduction will be performed in Child-Pugh score A or B. Duration of therapy will be performed in accordance with ESCMID guidelines and clinical conditions.

All Listed Sponsors
lead

Careggi Hospital

OTHER

NCT03798600 - Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization | Biotech Hunter | Biotech Hunter